Therapeutic Peri-implant Maintenance With Laser Therapy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04251793 |
Recruitment Status :
Enrolling by invitation
First Posted : February 5, 2020
Last Update Posted : December 22, 2020
|
Sponsor:
University of Michigan
Collaborator:
Morita J USA
Information provided by (Responsible Party):
Chin-Wei Wang, University of Michigan
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | January 30, 2020 | ||||
First Posted Date | February 5, 2020 | ||||
Last Update Posted Date | December 22, 2020 | ||||
Actual Study Start Date | July 8, 2019 | ||||
Estimated Primary Completion Date | April 30, 2021 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
Change in Periodontal Probing Depths (PD) [ Time Frame: Baseline and 6 months ] PD will be measured in millimeters. Change in PD measurements were calculated between baseline and 24 weeks
|
||||
Original Primary Outcome Measures | Same as current | ||||
Change History | |||||
Current Secondary Outcome Measures |
|
||||
Original Secondary Outcome Measures | Same as current | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | Therapeutic Peri-implant Maintenance With Laser Therapy | ||||
Official Title | Therapeutic Peri-implant Maintenance With Laser Therapy: An Extension of the LARST Study | ||||
Brief Summary | The present study represents an extension of the previously concluded randomized clinical trial "Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis" (HUM00124386). The aim of the study is to compare the adjunctive effect of laser over mechanical debridement alone in the maintenance of peri-implant tissues after surgical treatment of peri-implantitis (gum disease around implants). | ||||
Detailed Description | The same 24 subjects, previously treated with surgical regenerative treatment of peri-implantitis following the LARST protocol, will be invited to return for three follow-up visits. During the follow-up visits, clinical measurements, x-rays, and pictures of the inside of their mouth will be taken to evaluate the success of their peri-implantitis treatment. If needed, additional laser treatment of the dental implant may also be provided according to the same randomization of subjects in the original study. No placebo laser application will be provided. | ||||
Study Type | Observational | ||||
Study Design | Observational Model: Cohort Time Perspective: Cross-Sectional |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Non-Probability Sample | ||||
Study Population | Subjects who previously participated in the Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis study HUM00124386. | ||||
Condition | Peri-Implantitis | ||||
Intervention | Other: Observation
Soft tissue implant measurements and radiographs
|
||||
Study Groups/Cohorts |
|
||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Enrolling by invitation | ||||
Estimated Enrollment |
24 | ||||
Original Estimated Enrollment | Same as current | ||||
Estimated Study Completion Date | April 30, 2021 | ||||
Estimated Primary Completion Date | April 30, 2021 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
Premature Exclusion Criteria:
|
||||
Sex/Gender |
|
||||
Ages | Child, Adult, Older Adult | ||||
Accepts Healthy Volunteers | Not Provided | ||||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries | United States | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT04251793 | ||||
Other Study ID Numbers | HUM00160290 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement |
|
||||
Responsible Party | Chin-Wei Wang, University of Michigan | ||||
Study Sponsor | University of Michigan | ||||
Collaborators | Morita J USA | ||||
Investigators |
|
||||
PRS Account | University of Michigan | ||||
Verification Date | December 2020 |